SEPNSepterna, Inc.

SEPN Stock Price, Valuation & Chart | Septerna, Inc.

Compare

$37.500-0.18 (-0.48%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology SEPN intrinsic value SEPN calculated fair value vs price

Overview Financials Dividends Ratios

SEPN Historical price chart

SEPN Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization1.69B

PE Ratio-34.72

EPS-1.08

Trading Volume263.21K

Today's High/Low38.86/37.28

Dividend Yield0.00

52 Week High/Low51.1/12.32

Shares Outstanding45.08M

SEPN Financial Statement

SEPN Analyst ratings

SEPN Analysis & performance metrics

SEPN Company profile

Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of…

Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. The company develops SEP-786, an oral small molecule PTH1R agonist for hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 NAM for chronic…

SEPN Management team

Name

Position

Robert J. Lefkowitz M.D.

Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board

Gilbert M. Labrucherie C.F.A., J.D.CFO

Chief Financial Officer

Samira Shaikhly

Chief People Officer

George Xu Ph.D.CTO

Senior Director of Corporate Development & Portfolio Strategy

Jeffrey T. Finer M.D., Ph.D.CEO

Co-Founder, Chief Executive Officer, President & Director

Elizabeth P. Bhatt M.B.A., M.S.COO

Chief Operating Officer

Jae B. Kim FACC, M.D.

Chief Medical Officer

Arthur Christopoulos BPHARM, Ph.D.

Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board

Name

Position

Robert J. Lefkowitz M.D.

Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board

Gilbert M. Labrucherie C.F.A., J.D.CFO

Chief Financial Officer

Samira Shaikhly

Chief People Officer

George Xu Ph.D.CTO

Senior Director of Corporate Development & Portfolio Strategy

Jeffrey T. Finer M.D., Ph.D.CEO

Co-Founder, Chief Executive Officer, President & Director

Elizabeth P. Bhatt M.B.A., M.S.COO

Chief Operating Officer

Jae B. Kim FACC, M.D.

Chief Medical Officer

Arthur Christopoulos BPHARM, Ph.D.

Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board

Management Team

Robert J. Lefkowitz M.D.

Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board

Gilbert M. Labrucherie C.F.A., J.D.CFO

Chief Financial Officer

Samira Shaikhly

Chief People Officer

George Xu Ph.D.CTO

Senior Director of Corporate Development & Portfolio Strategy

Jeffrey T. Finer M.D., Ph.D.CEO

Co-Founder, Chief Executive Officer, President & Director

Elizabeth P. Bhatt M.B.A., M.S.COO

Chief Operating Officer

Jae B. Kim FACC, M.D.

Chief Medical Officer

Arthur Christopoulos BPHARM, Ph.D.

Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board

Management

Robert J. Lefkowitz M.D.

Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board

Gilbert M. Labrucherie C.F.A., J.D.CFO

Chief Financial Officer

Samira Shaikhly

Chief People Officer

George Xu Ph.D.CTO

Senior Director of Corporate Development & Portfolio Strategy

Jeffrey T. Finer M.D., Ph.D.CEO

Co-Founder, Chief Executive Officer, President & Director

Elizabeth P. Bhatt M.B.A., M.S.COO

Chief Operating Officer

Jae B. Kim FACC, M.D.

Chief Medical Officer

Arthur Christopoulos BPHARM, Ph.D.

Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board

Total 8 executives

SEPN Frequently asked questions

What is Septerna, Inc. (SEPN) Stock Price?

Current stock price of Septerna, Inc. (SEPN) stock is $37.500. The stock price is -0.48% lower in the session. The intraday range can be seen from this page. Volume of Septerna, Inc. (SEPN) stock is 263.21K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Septerna, Inc. (SEPN) stock price going up or down today?

The stock price of Septerna, Inc. (SEPN) can change with earnings, company news, and overall market sentiment. Septerna, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Septerna, Inc. stock expensive at its current price?

Whether Septerna, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SEPN on this page is -34.72. EPS on this page is -1.08. Compare those figures with peers and growth expectations before deciding if the current Septerna, Inc. price is justified.

How has the stock price of Septerna, Inc. (SEPN) performed historically?

Historical performance for Septerna, Inc. (SEPN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SEPN reacted to past earnings and market events.

Should I buy Septerna, Inc. (SEPN) stock, at this price?

Buying Septerna, Inc. (SEPN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.